Modifiable risk factors in women at high risk of breast cancer: a systematic review
- PMID: 37095519
- PMCID: PMC10123992
- DOI: 10.1186/s13058-023-01636-1
Modifiable risk factors in women at high risk of breast cancer: a systematic review
Abstract
Background: Modifiable risk factors (alcohol, smoking, obesity, hormone use, and physical activity) affect a woman's breast cancer (BC) risk. Whether these factors affect BC risk in women with inherited risk (family history, BRCA1/2 mutations, or familial cancer syndrome) remains unclear.
Methods: This review included studies on modifiable risk factors for BC in women with inherited risk. Pre-determined eligibility criteria were used and relevant data were extracted.
Results: The literature search resulted in 93 eligible studies. For women with family history, most studies indicated that modifiable risk factors had no association with BC and some indicated decreased (physical activity) or increased risk (hormonal contraception (HC)/menopausal hormone therapy (MHT), smoking, alcohol). For women with BRCA mutations, most studies reported no association between modifiable risk factors and BC; however, some observed increased (smoking, MHT/HC, body mass index (BMI)/weight) and decreased risk (alcohol, smoking, MHT/HC, BMI/weight, physical activity). However, measurements varied widely among studies, sample sizes were often small, and a limited number of studies existed.
Conclusions: An increasing number of women will recognize their underlying inherited BC risk and seek to modify that risk. Due to heterogeneity and limited power of existing studies, further studies are needed to better understand how modifiable risk factors influence BC risk in women with inherited risk.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
Prophylactic mastectomy for the prevention of breast cancer.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002748. doi: 10.1002/14651858.CD002748.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2010 Nov 10;(11):CD002748. doi: 10.1002/14651858.CD002748.pub3. PMID: 15495033 Updated.
-
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2. Cochrane Database Syst Rev. 2018. PMID: 30141832 Free PMC article.
-
Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 Jan 8;1:CD010216. doi: 10.1002/14651858.CD010216.pub8. PMID: 36384212 Free PMC article. Updated.
-
Long-term hormone therapy for perimenopausal and postmenopausal women.Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5. Cochrane Database Syst Rev. 2017. PMID: 28093732 Free PMC article.
-
Interventions for promoting habitual exercise in people living with and beyond cancer.Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3. Cochrane Database Syst Rev. 2018. PMID: 30229557 Free PMC article.
Cited by
-
Awareness and Risk Assessment of Breast Cancer Among Women in Saudi Arabia: A Cross-Sectional Study.Cureus. 2024 Jan 1;16(1):e51450. doi: 10.7759/cureus.51450. eCollection 2024 Jan. Cureus. 2024. PMID: 38298299 Free PMC article.
-
Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients.Int J Mol Sci. 2024 Apr 22;25(8):4561. doi: 10.3390/ijms25084561. Int J Mol Sci. 2024. PMID: 38674146 Free PMC article.
-
Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives.Curr Pharm Biotechnol. 2025;26(6):795-812. doi: 10.2174/0113892010299183240529094844. Curr Pharm Biotechnol. 2025. PMID: 38859783 Review.
-
Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort study.Breast Cancer Res Treat. 2025 Jul 22. doi: 10.1007/s10549-025-07786-4. Online ahead of print. Breast Cancer Res Treat. 2025. PMID: 40694191
-
Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania.Medicina (Kaunas). 2024 Mar 30;60(4):570. doi: 10.3390/medicina60040570. Medicina (Kaunas). 2024. PMID: 38674216 Free PMC article. Review.
References
-
- Office of the Associate Director for Science (OADS): Genomics & Precision Health. Knowing is not enough—act on your family health history. Centers for Disease Control and Prevention. 2020. Available from: https://www.cdc.gov/genomics/famhistory/knowing_not_enough.htm
-
- Regalado, Antonio. 2017 was the year consumer DNA testing blew up: More people took genetic ancestry tests last year than in all previous years combined. MIT Technol Rev: Biotechnol. 2018. technologyreview.com/2018/02/12/145676/2017-was-the-year-consumer-dna-te.... Accessed 25 Aug 2019.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous